NCT03879278View on ClinicalTrials.gov

Multiple Ascending Dose Study in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

June 27, 2019

Study Completion Date

June 27, 2019

Conditions
Amyloidosis
Interventions
DRUG

NPT189

NPT189 is a recombinant immunoglobulin Fc fusion of GAIM (GAIM-IgG1Fc) as a potential treatment for peripheral amyloidosis.

Trial Locations (1)

9728 NZ

PRA Health Sciences, Groningen

Sponsors
All Listed Sponsors
lead

Proclara Biosciences, Inc.

INDUSTRY